Figure 1
From: Lipidomic analysis enables prediction of clinical outcomes in burn patients
FFA and cytokine alterations in burn patients over time.
(A) All NEFAs. (B) Major FFA species (SFA, MuFA, and PuFA). (C) PuFAs sub-species (w3, w6, and w6:3 ratio). (D) Pro- and anti-inflammatory cytokines (IL-6, IL-1β, and IL-10). Shaded area represents values for normal controls. All data expressed as mean ± SEM. Asterisks indicate significance (p < 0.05) between control and clinical group compared. Double symbols indicate p < 0.01.
